Daxdilimab is an anti-ILT7 моноклональный антитело, ILT7 is a клетка surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research.
Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.